{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "Chelidonium majus", "case series", "greater celandine", "phytotherapy"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33778996", "DateCompleted": {"Year": "2021", "Month": "09", "Day": "14"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "03", "Day": "28"}], "Language": ["eng"], "ELocationID": ["10.1002/ptr.7085"], "Journal": {"ISSN": "1099-1573", "JournalIssue": {"Volume": "35", "Issue": "7", "PubDate": {"Year": "2021", "Month": "Jul"}}, "Title": "Phytotherapy research : PTR", "ISOAbbreviation": "Phytother Res"}, "ArticleTitle": "Greater celandine (Chelidonium majus L.) for COVID-19: A twenty-case series.", "Pagination": {"StartPage": "3792", "EndPage": "3798", "MedlinePgn": "3792-3798"}, "Abstract": {"AbstractText": ["In December 2019, an outbreak of coronavirus disease 2019 (COVID-19) occurred in Wuhan, China, with a rapid increase in cases worldwide. Until now, among several drugs tested, none demonstrated sufficient efficacy for its etiological treatment. Greater celandine (Chelidonium majus L.) is a well-known medicinal plant, traditionally indicated for digestive disorders and topically to remove warts. This study, performed at private offices in S\u00e3o Paulo and Aracaju (Brazil), describes 20 consecutive COVID-19 outpatients treated with greater celandine and their clinical evolution. The patients, aged 14-71\u2009years (median of 41\u2009years), were treated with Chelidonium majus 10% mother tincture, 20-30 drops three times a day for 3-12\u2009days (median of 5\u2009days). Clinical features were assessed during the treatment and at least until 1\u2009week after its end. These cases were considered mild, as most COVID-19 cases. The symptoms were mainly fever, fatigue, cough, sore throat, coryza, anosmia, ageusia, and headache. Ten patients had comorbidities, such as hypertension, diabetes, and overweight. Complete or almost complete clinical improvement occurred within 1-9\u2009days of treatment (median of 3\u2009days). There were no adverse events. This casuistry, although small, may inspire other researchers to continue investigating Chelidonium majus as a healing treatment for COVID-19."], "CopyrightInformation": "\u00a9 2021 John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": ["0000-0003-1114-6841"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Associa\u00e7\u00e3o Brasileira de Medicina Antropos\u00f3fica (Brazilian Association of Anthroposophic Medicine), Belo Horizonte, Brazil."}], "LastName": "Gardin", "ForeName": "Nilo E", "Initials": "NE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Associa\u00e7\u00e3o Brasileira de Medicina Antropos\u00f3fica (Brazilian Association of Anthroposophic Medicine), Belo Horizonte, Brazil."}], "LastName": "Braga", "ForeName": "Anne Jacqueline", "Initials": "AJ"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Phytother Res", "NlmUniqueID": "8904486", "ISSNLinking": "0951-418X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Preparations"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Brazil"}, {"QualifierName": ["chemistry"], "DescriptorName": "Chelidonium"}, {"QualifierName": [], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Preparations"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Young Adult"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Blumenthal, M. , Busse, W. R. , Goldberg, A. , Gruenwald, J. , Hall, T. , Riggins, C. W. , & Rister, R. S. (1998). The complete German commission E monographs: Therapeutic guide to herbal medicines. Austin, TX/Boston, MA: American Botanical Council/Integrative Medicine Communications."}, {"Citation": "Bone, K. , & Mills, S. (2013). Principles and practice of phytotherapy. Modern herbal medicine (2nd ed.). London, England: Elsevier."}, {"Citation": "Cai, Q. , Chen, F. , Wang, T. , Luo, F. , Liu, X. , Wu, Q. , \u2026 Xu, L. (2020). Obesity and COVID\u201019 severity in a designated hospital in Shenzhen, China. Diabetes Care, 43(7), 1392\u20131398. 10.2337/dc20-0576", "ArticleIdList": ["10.2337/dc20-0576", "32409502"]}, {"Citation": "European Scientific Cooperative on Phytotherapy (ESCOP) monographs . (2003). The scientific foundation for herbal medicinal products (2nd ed.). Stuttgart, Germany: Thieme."}, {"Citation": "Gardin, N. E. (2007). Chelidonium e Curcuma como imagem da fun\u00e7\u00e3o biliar. Arte M\u00e9dica Ampliada, 25(1\u20132), 13\u201316."}, {"Citation": "Gerencer, M. , Turecek, P. L. , Kistner, O. , Mitterer, A. , Savidis\u2010Dacho, H. , & Barrett, N. P. (2006). In vitro and in vivo anti\u2010retroviral activity of the substance purified from the aqueous extract of Chelidonium majus L. Antiviral Research, 72(2), 153\u2013156. 10.1016/j.antiviral.2006.03.008", "ArticleIdList": ["10.1016/j.antiviral.2006.03.008", "16647765"]}, {"Citation": "Gilca, M. , Gaman, L. , Panait, E. , Stoian, I. , & Atanasiu, V. (2010). Chelidonium majus\u2014An integrative review: Traditional knowledge versus modern findings. Forschende Komplementarmedizin, 17(5), 241\u2013248. 10.1159/000321397", "ArticleIdList": ["10.1159/000321397", "20980763"]}, {"Citation": "Golob, P. , Moss, C. , Dales, M. , Fidgen, A. , Evans, J. , & Gudrups, I. (2008). The use of spices and medicinals as bioactive protectants for grains. FAO Agricultural Services Bulletin: Rome, Italy."}, {"Citation": "Kienle, G. S. , & Kiene, H. (2009). Methodik der Einzelfallbeschreibung. Der Merkurstab, 62(3), 239\u2013242."}, {"Citation": "Kommission, C. (1999). Anthroposophische Arzneimittel\u2014Aufbereitungsmonographien der Kommission C (p. 956). Filderstadt, Germany: Gesellschaft Anthroposophischer \u00c4rzte in Deutschland."}, {"Citation": "Kommission, D. (1985). Aufbereitungsmonographien f\u00fcr Arzneimittel der hom\u00f6opathischen Therapierichtung. Chelidonium majus. Bundesanzeiger Nr. 190a vom 10.10.1985 Monographie BGA/BfArM. Berlin, Germany: Heilpflanzen\u2010Welt Bibliothek."}, {"Citation": "Lozjuk, R. M. , Lisnyak, O. I. , & Lozjuk, L. V. (1996). Theoretical grounds and experimental confirmation of the antiviral effect of the preparation Ukrain. Drugs under Experimental and Clinical Research, 22(3\u20135), 213\u2013217.", "ArticleIdList": ["8899334"]}, {"Citation": "Nawrot, J. , Wilk\u2010J\u0119drusik, M. , Nawrot, S. , Nawrot, K. , Wilk, B. , Dawid\u2010Pa\u0107, R. , \u2026 Gornowicz\u2010Porowska, J. (2020). Milky sap of greater celandine (Chelidonium majus L.) and anti\u2010viral properties. International Journal of Environmental Research and Public Health, 17(5), 1540\u20131547. 10.3390/ijerph17051540", "ArticleIdList": ["10.3390/ijerph17051540", "PMC7084376", "32120948"]}, {"Citation": "Orland, A. , Knapp, K. , K\u00f6nig, G. M. , Ulrich\u2010Merzenich, G. , & Kn\u00f6\u00df, W. (2014). Combining metabolomic analysis and microarray gene expression analysis in the characterization of the medicinal plant Chelidonium majus L. Phytomedicine, 21(12), 1587\u20131596. 10.1016/j.phymed.2014.07.012", "ArticleIdList": ["10.1016/j.phymed.2014.07.012", "25442267"]}, {"Citation": "Pelikan, W. (1997). Healing plants. Spring Valley: Mercury Press."}, {"Citation": "Siordia, J. A., Jr. (2020). Epidemiology and clinical features of COVID\u201019: A review of current literature. Journal of Clinical Virology, 127, 104357. 10.1016/j.jcv.2020.104357", "ArticleIdList": ["10.1016/j.jcv.2020.104357", "PMC7195311", "32305884"]}, {"Citation": "Wu, C. , Wang, X. , Xu, M. , Liu, Y. , & Di, X. (2019). Intracellular accumulation as an indicator of cytotoxicity to screen hepatotoxic components of Chelidonium majus L. by LC\u2013MS/MS. Molecules, 24(13), 2410. 10.3390/molecules24132410", "ArticleIdList": ["10.3390/molecules24132410", "PMC6651743", "31261913"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "1", "Day": "18"}, {"Year": "2020", "Month": "8", "Day": "21"}, {"Year": "2021", "Month": "2", "Day": "22"}, {"Year": "2021", "Month": "3", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "29", "Hour": "6", "Minute": "56"}, {"Year": "2021", "Month": "3", "Day": "28"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33778996", "PMC8250801", "10.1002/ptr.7085"]}}], "PubmedBookArticle": []}